ATYRNasdaq United States
Market cap
$50.143 M
$0.51 +1.87%
Close of 7 Aug 2026
Revenue
$190.0K
#3593 by revenue
Earnings
-$74.1M
Loss-making
Shares outstanding
98,087,425
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Atyr Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.